Corporate and commercial life sciences lawyer. Extensive international experience advising pharma, biotech and medical device companies on business development and IP transactions, commercial arrangements and regulation across product life cycles and business operations. Currently Assistant General Counsel in the Business Development and Corporate legal team of GSK. Advise on strategic BD transactions and alliance management. Examples:- Muna Therapeutics target discovery collaboration for AD- Relation Therapeutics target discovery collaborations for SSC and OA, and equity investment- Elsie Biotechnologies oligonucleotide discovery and synthesis collaboration and subsequent M&A to acquire company- Ochre Bio collaboration to create foundational biological dataset- LifeMine Therapeutics drug discovery and development collaboration and Series C equity investment- GSK-Oxford Institute of Molecular and Computational Medicine establishment - Adrestia Therapeutics collaboration and equity investment including subsequent acquisition by Insmed- 23andMe drug discovery and development collaboration and equity investment including subsequent de-SPAC transaction to go public- Broad Institute variant to function collaboration in functional genomics- Laboratory for Genomic Research established with the University of California- Lentiviral stable cell line technology out-licence to Orchard Therapeutics for its gene therapies- Apollo Therapeutics joint venture and subsequent corporate restructuring and financing rounds - Our Future Health founding industry membership including access to NHS England data- UK Biobank whole genome sequencing project with investment from government, industry and charity- GSK AI London hub establishment in collaboration with NVIDIA and academic partnersPrior to current GSK role was seconded from private practice to GSK’s Pharma R&D Legal Operations team. Advised on a wide range of clinical and preclinical contracting and regulatory issues.Joined GSK permanently from global law firm Norton Rose Fulbright. There had a leading role as Of Counsel in the life sciences team. The team ranked in The Legal 500 UK 2017 and was described as ‘a professional team’ providing ’quality advice’. Personally recommended by a client in the directory. Prior to a legal career, studied chemistry to a postgraduate level and then worked as a chemist at pharmaceutical company Mylan. A scientific background together with extensive legal experience focused on the life sciences sector enables the provision of high quality legal services.